CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. Between 74-89% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. Please refer to our Risk Disclosure Statement
Open platformOpen platform

NewAmsterdam Pharma Grants 106,600 Share Options to Six New Hires

By Public Technologies
  • NewAmsterdam Pharma granted share options covering 106,600 ordinary shares to six non-executive new hires under its 2024 Inducement Plan.
  • Restricted stock units covering 28,295 ordinary shares went to six non-executive new hires. Both grants were dated November 2, 2026.
  • Share options vest over four years: 25% on the first vesting anniversary, with the balance in 36 equal monthly installments.
  • Restricted stock units vest over three years, with one-third vesting on each annual anniversary of the vesting commencement date.
  • Vesting of both awards depends on continued service.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NewAmsterdam Pharma Company NV published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611061601PRIMZONEFULLFEED9871874) on November 06, 2026, and is solely responsible for the information contained therein.

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk